These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 17923426

  • 41. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.
    Feringa HH, Karagiannis SE, Chonchol M, Vidakovic R, Noordzij PG, Elhendy A, van Domburg RT, Welten G, Schouten O, Bax JJ, Berl T, Poldermans D.
    J Am Soc Nephrol; 2007 Jun; 18(6):1872-9. PubMed ID: 17475817
    [Abstract] [Full Text] [Related]

  • 42. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U, Kirchberger I, Heier M, Zirngibl A, von Scheidt W, Kuch B, Peters A, Meisinger C.
    Am J Cardiol; 2014 Aug 01; 114(3):329-35. PubMed ID: 24927969
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
    Winkel TA, Hoeks SE, Schouten O, Zeymer U, Limbourg T, Baumgartner I, Bhatt DL, Steg PG, Goto S, Röther J, Cacoub PP, Verhagen HJ, Bax JJ, Poldermans D.
    Eur J Vasc Endovasc Surg; 2010 Jul 01; 40(1):9-16. PubMed ID: 20385507
    [Abstract] [Full Text] [Related]

  • 46. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM.
    Can J Cardiol; 2005 May 01; 21(6):485-8. PubMed ID: 15917876
    [Abstract] [Full Text] [Related]

  • 47. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
    Mancini GB, Etminan M, Zhang B, Levesque LE, FitzGerald JM, Brophy JM.
    J Am Coll Cardiol; 2006 Jun 20; 47(12):2554-60. PubMed ID: 16781387
    [Abstract] [Full Text] [Related]

  • 48. Age- and gender-related differences in the use of secondary medical prevention after primary vascular surgery: a nationwide follow-up study.
    Høgh A, Lindholt JS, Nielsen H, Jensen LP, Johnsen SP.
    Eur J Vasc Endovasc Surg; 2012 Mar 20; 43(3):300-7. PubMed ID: 22244910
    [Abstract] [Full Text] [Related]

  • 49. Secondary medical prevention after primary vascular surgery between 1996 and 2006: a shift towards more evidence-based treatment.
    Høgh A, Lindholt JS, Nielsen H, Jensen LP, Johnsen SP.
    Eur J Prev Cardiol; 2013 Oct 20; 20(5):763-70. PubMed ID: 22637739
    [Abstract] [Full Text] [Related]

  • 50. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A, Fonarow GC, Eagle KA, Hirsch AT, Califf RM, Alberts MJ, Boden WE, Steg PG, Shao M, Bhatt DL, Cannon CP, REACH Investigators.
    Crit Pathw Cardiol; 2009 Sep 20; 8(3):104-11. PubMed ID: 19726929
    [Abstract] [Full Text] [Related]

  • 51. Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction.
    Austin PC, Tu JV, Ko DT, Alter DA.
    CMAJ; 2008 Oct 21; 179(9):895-900. PubMed ID: 18936454
    [Abstract] [Full Text] [Related]

  • 52. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.
    Pilote L, Beck CA, Karp I, Alter D, Austin P, Cox J, Humphries K, Jackevicius C, Richard H, Tu JV, Canadian Cardiovascular Outcomes Research Team.
    Can J Cardiol; 2004 Jan 21; 20(1):61-7. PubMed ID: 14968144
    [Abstract] [Full Text] [Related]

  • 53. The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics.
    Cambou JP, Simon T, Mulak G, Bataille V, Danchin N.
    Arch Mal Coeur Vaiss; 2007 Jan 21; 100(6-7):524-34. PubMed ID: 17893635
    [Abstract] [Full Text] [Related]

  • 54. Comparison of evidence-based versus non-evidence-based pharmacotherapy on the risk of cardiovascular hospitalization and all-cause mortality among patients with established cardiovascular disease.
    Nichols GA, Wang F, Pedula KL.
    Am J Cardiol; 2010 Mar 15; 105(6):786-91. PubMed ID: 20211320
    [Abstract] [Full Text] [Related]

  • 55. Hospital variation in use of secondary preventive medicine after discharge for first acute myocardial infarction during 1995-2004.
    Rasmussen S, Abildstrom SZ, Rasmussen JN, Gislason GH, Schramm TK, Folke F, Køber L, Torp-Pedersen C, Madsen M.
    Med Care; 2008 Jan 15; 46(1):70-7. PubMed ID: 18162858
    [Abstract] [Full Text] [Related]

  • 56. Association of early follow-up after acute myocardial infarction with higher rates of medication use.
    Daugherty SL, Ho PM, Spertus JA, Jones PG, Bach RG, Krumholz HM, Peterson ED, Rumsfeld JS, Masoudi FA.
    Arch Intern Med; 2008 Mar 10; 168(5):485-91; discussion 492. PubMed ID: 18332293
    [Abstract] [Full Text] [Related]

  • 57. Use and cost of branded and generic drugs in patients with coronary heart disease--results from a prospective survey of 1008 patients in two London hospitals.
    Corp EV, Antoniou S, Wright PG, Khachi H, Vercaeren S, Wald DS.
    QJM; 2009 Dec 10; 102(12):843-9. PubMed ID: 19828644
    [Abstract] [Full Text] [Related]

  • 58. [Myocardial infarction--risks and procedures. Longitudinal observation of a population of 280,000 women and men--Project POL-MONICA Krakow. I V: Prognosis of non-invasive treatment in myocardial infarction within 28 days since its onset].
    Pajak A.
    Przegl Lek; 1996 Dec 10; 53(11):779-84. PubMed ID: 9173438
    [Abstract] [Full Text] [Related]

  • 59. High prevalence of undiagnosed patients with peripheral arterial disease in patients hospitalised for non-vascular disorders.
    Lacroix P, Aboyans V, Voronin D, Le Guyader A, Cautrès M, Laskar M.
    Int J Clin Pract; 2008 Jan 10; 62(1):59-64. PubMed ID: 18028389
    [Abstract] [Full Text] [Related]

  • 60. Treatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary prevention.
    Kvan E, Pettersen KI, Landmark K, Reikvam A, INPHARM study investigators.
    Pharmacoepidemiol Drug Saf; 2006 Apr 10; 15(4):261-7. PubMed ID: 16315337
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.